Autosomal recessive bestrophinopathy
MONDO:0012733Autosomal recessive bestrophinopathy (ARB) is a retinal dystrophy, characterized by central visual loss in the first 2 decades of life, associated with an absent electrooculogram (EOG) light rise and a reduced electroretinogram (ERG).
Also known as: retinopathy, Burgess-Black type, ARB, bestrophinopathy, autosomal recessive
29 clinical trials for this condition and its sub-types, 2 tagged with Autosomal recessive bestrophinopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Gene therapy injection aims to halt rare blindness
Disease control Recruiting nowThis early-stage trial tests a gene therapy called OPGx-BEST1 for two rare inherited eye diseases that cause vision loss. About 10 adults will receive a single injection into one eye to see if it is safe and to find the best dose. The study will follow participants for 5 years to…
Phase 1/2 • Sponsor: Opus Genetics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Everyday drugs might tame COVID: 3,000-Patient trial launched
Knowledge-focused Recruiting nowThis study looks back at 3,000 hospital patients to see if those who got a flu shot, took blood pressure meds (ACEI/ARB), antihistamines, or amantadine had better COVID-19 outcomes. Researchers want to know if these common treatments can reduce deaths or shorten hospital stays. N…
Sponsor: Consorci Sanitari de Terrassa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC